Your browser doesn't support javascript.
loading
Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial.
Zunder, Stéphanie; van der Wilk, Priscilla; Gelderblom, Hans; Dekker, Tim; Mancao, Christoph; Kiialainen, Anna; Putter, Hein; Tollenaar, Rob; Mesker, Wilma.
Afiliação
  • Zunder S; Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, Netherlands.
  • van der Wilk P; Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands.
  • Gelderblom H; Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, Netherlands.
  • Dekker T; Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands.
  • Mancao C; Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, Netherlands.
  • Kiialainen A; Oncology Biomarker Development, F. Hoffmann-La Roche Ltd, CH-4070, Basel, Switzerland.
  • Putter H; Oncology Biomarker Development, F. Hoffmann-La Roche Ltd, CH-4070, Basel, Switzerland.
  • Tollenaar R; Department of Medical Statistics, Leiden University Medical Centre, Leiden, Netherlands.
  • Mesker W; Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, Netherlands.
Cell Oncol (Dordr) ; 42(5): 717-725, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31102145

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Células Estromais / Neoplasias do Colo / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Células Estromais / Neoplasias do Colo / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2019 Tipo de documento: Article